| pubmed-article:8175190 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8175190 | lifeskim:mentions | umls-concept:C0003392 | lld:lifeskim |
| pubmed-article:8175190 | lifeskim:mentions | umls-concept:C0031228 | lld:lifeskim |
| pubmed-article:8175190 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:8175190 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:8175190 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:8175190 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8175190 | pubmed:dateCreated | 1994-6-9 | lld:pubmed |
| pubmed-article:8175190 | pubmed:abstractText | Urinary platinum levels of 21 nurses and hospital pharmacy personnel occupationally exposed to platinum containing antineoplastic drugs were determined in 24-h urine by voltammetric analysis after UV photolysis. All study participants applied standard safety measures, including a vertical laminar air-flow cabinet and latex gloves. The amount of platinum-containing drugs prepared for intravenous application ranged from 40-3260 mg/day. Urinary platinum was detected in 9 of 52 urine samples collected on days when platinum-containing drugs were mixed (limit of determination 4 ng/l). In comparison with a non-exposed control group, elevated urinary platinum levels were found in one pharmacist (35 ng/g creatinine) and one pharmacy technician (28 ng/g creatinine). The pharmacist's urinary platinum remained elevated after 2 days without occupational exposure to antineoplastic drugs. The urinary platinum level of the pharmacy technician dropped considerably after several weeks without handling cytostatic drugs. Voltammetric detection of urinary platinum is a highly sensitive method suitable for biological and environmental monitoring. | lld:pubmed |
| pubmed-article:8175190 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8175190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8175190 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8175190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8175190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8175190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8175190 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8175190 | pubmed:issn | 0340-0131 | lld:pubmed |
| pubmed-article:8175190 | pubmed:author | pubmed-author:FruhmannGG | lld:pubmed |
| pubmed-article:8175190 | pubmed:author | pubmed-author:PethranAA | lld:pubmed |
| pubmed-article:8175190 | pubmed:author | pubmed-author:EnsslinA SAS | lld:pubmed |
| pubmed-article:8175190 | pubmed:author | pubmed-author:SchierlRR | lld:pubmed |
| pubmed-article:8175190 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8175190 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:8175190 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8175190 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8175190 | pubmed:pagination | 339-42 | lld:pubmed |
| pubmed-article:8175190 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:meshHeading | pubmed-meshheading:8175190-... | lld:pubmed |
| pubmed-article:8175190 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8175190 | pubmed:articleTitle | Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs. | lld:pubmed |
| pubmed-article:8175190 | pubmed:affiliation | Institut und Poliklinik für Arbeitsmedizin, Universität München, Germany. | lld:pubmed |
| pubmed-article:8175190 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175190 | lld:pubmed |
